Avacopan ADVOCATE Study Design
Lopsided Avacopan ADVOCATE Study Design Continue reading Avacopan ADVOCATE Study Design
DRUG DEVELOPMENT IN CHINA – Moving Beyond the Me-Too Path
We have to thank Liu and colleagues for a thorough review of pharmaceutical development activities in China and elsewhere during the last decade.[1] The authors reviewed a total of 34,844 Phase 1-3 trials, showing a significant uptick in studies initiated by Chinese companies. Compared to 2015, trial numbers have steadily Continue reading DRUG DEVELOPMENT IN CHINA – Moving Beyond the Me-Too Path
ANTIBIOTIC DEVELOPMENT IN PHARMA IS DEAD – FOR NOW
This is a somewhat nostalgic retro blog. I was leafing through a book by Vince Andriole called ‘The Quinolones’.[1] First released in 1988, its third edition is from 2000. It provided in-depth coverage of quinolone chemistry, PK, microbiology, efficacy and safety. It was a great review of the large and Continue reading ANTIBIOTIC DEVELOPMENT IN PHARMA IS DEAD – FOR NOW